Regado BioSciences, Inc.
生物技术研究
Bernards，New Jersey 45 位关注者
The Only Antithrombotic Therapy with True Reversibility
关于我们
Regado Biosciences, Inc. is a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications. Regado is pioneering the discovery and development of two-component drug systems consisting of a therapeutic aptamer and its specific active control agent. The company’s lead product candidate, REG1, is an actively controllable anticoagulant targeting coagulation Factor IXa for use in patients with a wide variety of acute coronary syndromes, or ACS, undergoing a percutaneous coronary intervention, or PCI, a hospital-based procedure used to mechanically open or widen obstructed coronary arteries. The actively controllable product candidates have the potential to improve outcomes, enhance the patient experience and reduce overall treatment costs.
- 网站
-
https://www.regadobiosciences.net
Regado BioSciences, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Bernards，New Jersey
- 类型
- 私人持股
地点
-
主要
获取路线
120 Mountainview Blvd
US，New Jersey，Bernards，07920